课题基金 / 基金详情

Novel cytotoxins purified from methicillin-resistant staphylococcus aureus

Novel cytotoxins purified from methicillin-resistant staphylococcus aureus
从耐甲氧西林金黄色葡萄球菌中纯化出新型细胞毒素
批准号:
06454203
负责人:
NODA Masatoshi
金额:
$4.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NODA Masatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
对从重症监护病房住院患者中分离出的耐甲氧西林金黄色葡萄球菌(MRSA)的两种新型细胞毒素hl -细胞毒素和hs -细胞毒素进行了纯化。这些纯化的毒素与已有报道的中毒性休克综合征毒素1 (TSST-1)、肠毒素、α毒素、δ毒素、杀白细胞素和脱叶毒素等葡萄球菌外毒素明显不同。hl -细胞毒素和hs -细胞毒素的分子量分别约为50,000和40,000。这些毒素对人类胚胎细胞转化劳斯肉瘤病毒的Vero细胞、CHO细胞和RSa-UV^r细胞具有细胞毒性。在60℃加热10 min后,hl -细胞毒素失去了细胞毒活性。另一方面,在80℃加热30 min时,hs -细胞毒素的细胞毒性仍然稳定。这些毒素对人和家兔红细胞没有溶血活性。hl -细胞毒素和hs -细胞毒素对小鼠也有致死作用。进一步的实验试图阐明这些从MRSA中纯化的毒素对RSa-UV^r细胞的作用模式,目前正在进行中。
英文摘要
Two novel cytotoxins designated HL-cytotoxin and HS-cytotoxin of methicillin-resistant Staphylococcus aureus (MRSA) which was isolated from a patient hospitalized at an intensive care unit were purified. These purified toxins were distinctly different from staphlococcal exotoxins reported already such as toxic shock syndrome toxin 1 (TSST-1), enterotoxins, alpha-toxins, delta-toxins, leukocidin and exofoliative toxins. The molecular weights of the HL-cytotoxin and HS-cytotoxin were approximately 50,000 and 40,000, respectively. These toxins were cytotoxic to Vero cells, CHO cells and RSa-UV^r cells which are human embryonic cells transformed Rous sarcoma virus. The HL-cytotoxin lost its cytotoxic activity when it was heated at 60 C for 10 min. On the other hand, the cytotoxicity of the HS-cytotoxin was still stable when it was heated at 80 C for 30 min. No hemolytic activity of these toxins to human and rabbit erythrocytes was observed. The HL-cytotoxin and the HS-cytotoxin possessed also lethal activities to mice. Further experiments attempting to clarify the mode of action of these toxins purified from MRSA on RSa-UV^r cells are in progress.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
野田 公俊: "コレラ菌の毒素" Medical Immunology. 27. 407-414 (1994)
Kimitoshi Noda:“霍乱弧菌毒素”医学免疫学 27. 407-414 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Morinaga: "Differentiation of HL-60 cells is promoted by H-toxin" FEBS Letters. 351. 317-320 (1994)
N.Morinaga:“H 毒素促进 HL-60 细胞的分化”FEBS Letters。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Nishikawa: "Possible involvement of lipoxygenese Metabolites" J.Biochem.116. 833-837 (1994)
T.Nishikawa:“脂氧化代谢物可能参与”J.Biochem.116。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mitsuo Nagase, et al.: "Primiting effect of hydroxyapatite on the chemiluminescence response in human polymorphonuclear leukocytes." FEBS Lett.349. 13-16 (1994)
Mitsuo Nagase 等人:“羟基磷灰石对人多形核白细胞化学发光反应的启动作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 25 条
    Elucidation of Shiga-toxigenic Escherichia coli produced Subtilase cytotoxin-induced cell damage mechanism.
    • 批准号:
      21390127
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2009
    • 负责人:
      NODA Masatoshi
    • 依托单位:
    Studies on the SubAB toxin, its target organs, and its quick identification
    • 批准号:
      19390124
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2007
    • 负责人:
      NODA Masatoshi
    • 依托单位:
    Development of a quick neutralization therapy for the diseases caused by bacterial toxins
    • 批准号:
      15209016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.7万
    • 财政年份:
      2003
    • 负责人:
      NODA Masatoshi
    • 依托单位:
    Development of a quick diagnosis of Haemophilus influenzea Which induces Guillain- Barre syndrome.
    • 批准号:
      13307010
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.12万
    • 财政年份:
      2001
    • 负责人:
      NODA Masatoshi
    • 依托单位:
    国内基金
    海外基金
    去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢颖
    • 依托单位:
    小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
    野菊花内生真菌中抗MRSA活性成分及其作用机制
    • 批准号:
      JCZRLH202601040
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
    • 批准号:
      2026JJ50552
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      吴苑
    • 依托单位: